S. Rouan
Vermogen: 40 598 $ op 31-05-2026
Vermogen: 40 598 $ op 31-05-2026
S.
Kathryn Rouan is currently Non-Executive Director at Code Biotherapeutics, Inc. and Independent Director at Viking Therapeutics, Inc. since 2019.
Former roles include Chairman at Navidea Biopharmaceuticals, Inc. from 2018 to 2021, Senior VP, Head-Research & Development at Stiefel Laboratories, Inc. from 2013 to 2016, SVP, Head-Projects, Clinical Platforms & Sciences at GlaxoSmithKline LLC from 2016 to 2018, and Vice President at GlaxoSmithKline LLC from 2003 to 2013.
Education includes a doctorate from the University of Rhode Island.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2026 | 1.240 ( 0% ) | 40 598 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-07-2019 |
Code Biotherapeutics, Inc.
Code Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Voorzitter | 14-09-2021 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01-12-2018 |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 01-05-2016 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01-12-2013 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes precision diagnostics and radiopharmaceutical agents | Health Technology |
University of Rhode Island
University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Viking Therapeutics, Inc.
Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
Code Biotherapeutics, Inc.
Code Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau